Generalized Anxiety Disorder Symptoms among Persons with Diagnosed HIV in the United States—2015–2016, Medical Monitoring Project
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All
i


Generalized Anxiety Disorder Symptoms among Persons with Diagnosed HIV in the United States—2015–2016, Medical Monitoring Project

Filetype[PDF-90.44 KB]


  • English

  • Details:

    • Alternative Title:
      AIDS
    • Description:
      Objective: To estimate the prevalence of Generalized Anxiety Disorder (GAD) symptoms among adults with diagnosed HIV (PWH) in the United States in order to inform effective HIV prevention and care efforts. Design: The Medical Monitoring Project (MMP) is a complex sample survey of adults with diagnosed HIV in the United States. Methods: We used MMP data collected during 6/2015–5/2016 to calculate the weighted prevalence of GAD symptoms among PWH (N=3654) and prevalence ratios with predicted marginal means to evaluate significant differences between groups. Results: The estimated prevalence of GAD symptoms among PWH was 19%. GAD symptoms were associated with significantly lower antiretroviral therapy prescription and adherence, medical HIV care engagement, and sustained viral suppression. Persons with GAD symptoms were over 3 times as likely to have an unmet need for mental health services (23% vs. 7%) and had significantly more emergency room visits and hospitalizations than those without these symptoms. GAD symptoms were associated with significantly higher prevalence of condomless sex while not sustainably virally suppressed with a person not known to be taking preexposure prophylaxis (9% vs. 6%). Conclusions: GAD symptom prevalence among PWH was considerably higher than among the U.S. general adult population, indicating an excess burden of anxiety among PWH. Outcomes along the HIV care continuum were poorer, and risk for HIV transmission was higher, among persons with symptoms. Incorporating routine screening for GAD in HIV clinical settings may help improve health outcomes, reduce HIV transmission, and save healthcare costs.
    • Source:
      AIDS. 33(11):1781-1787
    • Pubmed ID:
      31211718
    • Pubmed Central ID:
      PMC6663599
    • Document Type:
    • Place as Subject:
    • Collection(s):
    • Main Document Checksum:
    • File Type:

    Supporting Files

    More +

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov